Skip to main content
. 2023 Jun 7;78(6):1698–1710. doi: 10.1097/HEP.0000000000000502

TABLE 1.

Clinical and laboratory characteristics

Clinical and laboratory characteristics Baseline (N = 76) Week 48 (N = 76)
ItchRO(Obs) scorea 2.7 (2.1, 3.1) 1.14 (0.24, 1.86)
Weight z-score −1.41 (−2.15, −0.67) −1.40 (−2.05, −0.63)
Height z-score −1.50 (−2.29, −0.95) −1.45 (−2.35, −0.81
Total bilirubin (mg/dL) 2.3 (0.9, 8.4) 2.0 (0.9, 8.1)
Direct bilirubin (mg/dL) 1.7 (0.6, 7.0) 1.7 (0.6, 6.8)
sBA (μmol/L) 184 (78, 361) 100 (43, 194)
Albumin (g/dL) 4.6 (4.3, 4.7) 4.6 (4.3, 4.7)
ALT (U/L) 134 (95, 193) 181 (125, 237)
AST (U/L) 130 (96, 185) 155 (110, 209)
GGT (U/L) 392 (188, 751) 418 (285, 663)
International normalized ratio 1.00 (1.00, 1.10) 1.00 (1.00, 1.10)
Platelets (×109/L) 293 (223, 383) 252 (195, 346)

Note: All data are median (Q1, Q3).

a

ItchRO(Obs) score recorded as weekly morning average.

Abbreviations: GGT, gamma-glutamyl transferase; ItchRO(Obs), Itch-Reported Outcome (Observer); sBA, serum bile acids.